Surrozen, Inc. (SRZN)
NASDAQ·Healthcare·Biotechnology
$23.47
+0.43%
Mkt Cap $227.49M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$42.00
Range $40.00 – $44.00
Implied Upside
+79.0%
Consensus $42.00 vs current $23.47
NASDAQ·Healthcare·Biotechnology
$23.47
+0.43%
Mkt Cap $227.49M
No recent rating data.
Price Target (4 analysts)
$42.00
Range $40.00 – $44.00
+79.0%
Consensus $42.00 vs current $23.47